FebriDx® Wins Biomarkers Award at 2019 UK Diagnostics Summit
SARASOTA, Fla.–(BUSINESS WIRE)–#POC—Lumos Diagnostics, a point-of-care (POC) diagnostic test developer, manufacturer and marketer received the Biomarkers Award at the recent…
Pharmaceuticals, Biotechnology and Life Sciences
SARASOTA, Fla.–(BUSINESS WIRE)–#POC—Lumos Diagnostics, a point-of-care (POC) diagnostic test developer, manufacturer and marketer received the Biomarkers Award at the recent…
Swiss-based Roche’s is buying Spark Therapeutics for of $114.50 per share in cash, total $4.3 billion through its fully owned subsidiary 022019 Merger Subsidiary.
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on November 1, 2019 and December 2, 2019…
Receives Notice of Allowance on Patent Protection for Orally Available ROCK2 Inhibitor BOSTON–(BUSINESS WIRE)–Please replace the release with the following…
MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured,…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) reported financial results for the fiscal year ended September 30, 2019. The Company…
HENSIFY® is a first-in-class “radioenhancer” that consists of hafnium oxide nanoparticles which increases the tumor-killing effect of radiation therapy without…
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE…
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global eczema therapeutics market and the market is poised to grow by USD 3.60…
Receives Notice of Allowance on Patent Protection for Orally Available ROCK2 Inhibitor BOSTON–(BUSINESS WIRE)–BioAxone BioSciences, Inc., a biotechnology company committed…